Alkem Laboratories Limited (BOM: 539523)

Alkem Laboratories Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Operating Revenue	127,062	126,676	115,993	106,342	88,650	83,444
Other Revenue	1,258	-	-	-	-	-
Revenue	128,319	126,676	115,993	106,342	88,650	83,444
Revenue Growth (YoY)	3.89%	9.21%	9.08%	19.96%	6.24%	13.42%
Cost of Revenue	48,192	50,642	50,207	42,806	35,751	34,233
Gross Profit	80,128	76,034	65,785	63,536	52,899	49,211
Selling, General & Admin	31,227	30,329	29,726	25,769	19,807	20,853
Other Operating Expenses	22,725	23,041	19,760	17,305	13,617	13,180
Operating Expenses	57,070	56,359	52,589	46,103	36,160	36,551
Operating Income	23,058	19,676	13,196	17,432	16,739	12,660
Interest Expense	-775.4	-803.8	-809.2	-308.9	-398.7	-466.1
Interest & Investment Income	2,758	2,758	1,711	1,227	901.2	632.3
Currency Exchange Gain (Loss)	-335.1	-335.1	-188.6	-16.5	458.4	45.5
Other Non Operating Income (Expenses)	12.2	12.2	-12.8	-24.2	-36.7	-82.6
EBT Excluding Unusual Items	24,717	21,307	13,897	18,309	17,664	12,789
Gain (Loss) on Sale of Investments	151.7	151.7	308.6	114.5	369.5	-171.4
Gain (Loss) on Sale of Assets	-31.8	-31.8	-123.6	19.7	388	12.7
Asset Writedown	-	-576.6	-1,051	-11.2	-	-32.7
Other Unusual Items	-618.5	-618.5	17.4	10.5	-	-
Pretax Income	24,219	20,231	13,048	18,443	18,421	12,598
Income Tax Expense	2,609	2,117	2,980	1,640	2,243	1,105
Earnings From Continuing Operations	21,610	18,115	10,068	16,803	16,178	11,493
Minority Interest in Earnings	-386.4	-156.9	-226.4	-347	-327.5	-222.4
Net Income	21,223	17,958	9,842	16,456	15,850	11,271
Net Income to Common	21,223	17,958	9,842	16,456	15,850	11,271
Net Income Growth	48.11%	82.47%	-40.19%	3.82%	40.63%	48.20%
Shares Outstanding (Basic)	120	120	120	120	120	120
Shares Outstanding (Diluted)	120	120	120	120	120	120
Shares Change (YoY)	-0.01%	-	-	-	-	-
EPS (Basic)	177.51	150.19	82.31	137.63	132.57	94.26
EPS (Diluted)	177.51	150.19	82.31	137.63	132.57	94.26
EPS Growth	48.12%	82.47%	-40.19%	3.82%	40.63%	48.20%
Free Cash Flow	15,054	16,888	14,496	7,721	10,700	2,220
Free Cash Flow Per Share	125.91	141.24	121.24	64.58	89.49	18.57
Dividend Per Share	5.000	40.000	25.000	34.000	30.000	25.000
Dividend Growth	-88.89%	60.00%	-26.47%	13.33%	20.00%	56.25%
Gross Margin	62.44%	60.02%	56.72%	59.75%	59.67%	58.97%
Operating Margin	17.97%	15.53%	11.38%	16.39%	18.88%	15.17%
Profit Margin	16.54%	14.18%	8.48%	15.47%	17.88%	13.51%
Free Cash Flow Margin	11.73%	13.33%	12.50%	7.26%	12.07%	2.66%
EBITDA	25,781	22,268	15,893	20,122	19,147	14,858
EBITDA Margin	20.09%	17.58%	13.70%	18.92%	21.60%	17.81%
D&A For EBITDA	2,723	2,592	2,697	2,690	2,408	2,198
EBIT	23,058	19,676	13,196	17,432	16,739	12,660
EBIT Margin	17.97%	15.53%	11.38%	16.39%	18.88%	15.17%
Effective Tax Rate	10.77%	10.46%	22.84%	8.89%	12.18%	8.77%
Revenue as Reported	131,428	129,784	118,153	107,968	90,982	84,486

Source: S&P Capital IQ. Standard template. Financial Sources.